A VALIDATION, WITH NEW CLINICAL APPLICABILITY, OF A CLINICAL‐GENETIC RISK MODEL THAT PREDICTS THROMBOSIS WITH HIGH SENSITIVITY IN PATIENTS WITH LYMPHOMA
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2019-06, Vol.37 (S2), p.534-534 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 534 |
|---|---|
| container_issue | S2 |
| container_start_page | 534 |
| container_title | Hematological oncology |
| container_volume | 37 |
| creator | Bastos‐Oreiro, M. Ortiz, J. Pradillo, V. Martinez‐Laperche, C. Salas, E. Buño Borde, I. Díez‐Martín, J. Soria, J. Pascual, C. |
| description | |
| doi_str_mv | 10.1002/hon.219_2631 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2242708882</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2242708882</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1541-12569fd1bdc832f1485e1301961cc546b387528df6e3255e18c70f5033ec4b4c3</originalsourceid><addsrcrecordid>eNp9kM1OwkAUhSdGExHd-QCTuKU4P22ZLksZ6MT-hY4QVhMobYQgxVZi2PkIrn08n8QhRZau7r053z0nOQDcY9TFCJHHl3LbJdhRxKb4ArQwchwDI9u5BC1EesxAhJJrcFPXa4S0hlgLfLtw4gZi4EoRRx04FdKHEZ9CLxCR8NwAukkS6KUvAiFnHRgPoXsWfz6_RjziUnhwLNInGMYDHkDpuxImYz4Qnkz1NY7DfpyKtDH3xciHKY9SIcVEW0IRwUSn80ieiGAWJn4curfgqphv6vzuNNvgecil5xtBPDqmGxm2TGxgYtlOscSLZcYoKbDJrBxThB0bZ5ll2gvKehZhy8LOKbG0xrIeKixEaZ6ZCzOjbfDQ-O6q8m2f1-9qXe6rrY5UhJikhxhjRFOdhsqqsq6rvFC7avU6rw4KI3VsX-n21V_7Grca_GO1yQ__ssqPo_PfLw58e-8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242708882</pqid></control><display><type>article</type><title>A VALIDATION, WITH NEW CLINICAL APPLICABILITY, OF A CLINICAL‐GENETIC RISK MODEL THAT PREDICTS THROMBOSIS WITH HIGH SENSITIVITY IN PATIENTS WITH LYMPHOMA</title><source>Wiley Online Library All Journals</source><creator>Bastos‐Oreiro, M. ; Ortiz, J. ; Pradillo, V. ; Martinez‐Laperche, C. ; Salas, E. ; Buño Borde, I. ; Díez‐Martín, J. ; Soria, J. ; Pascual, C.</creator><creatorcontrib>Bastos‐Oreiro, M. ; Ortiz, J. ; Pradillo, V. ; Martinez‐Laperche, C. ; Salas, E. ; Buño Borde, I. ; Díez‐Martín, J. ; Soria, J. ; Pascual, C.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.219_2631</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Lymphoma ; Thromboembolism ; Thrombosis</subject><ispartof>Hematological oncology, 2019-06, Vol.37 (S2), p.534-534</ispartof><rights>2019 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1541-12569fd1bdc832f1485e1301961cc546b387528df6e3255e18c70f5033ec4b4c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.219_2631$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.219_2631$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Bastos‐Oreiro, M.</creatorcontrib><creatorcontrib>Ortiz, J.</creatorcontrib><creatorcontrib>Pradillo, V.</creatorcontrib><creatorcontrib>Martinez‐Laperche, C.</creatorcontrib><creatorcontrib>Salas, E.</creatorcontrib><creatorcontrib>Buño Borde, I.</creatorcontrib><creatorcontrib>Díez‐Martín, J.</creatorcontrib><creatorcontrib>Soria, J.</creatorcontrib><creatorcontrib>Pascual, C.</creatorcontrib><title>A VALIDATION, WITH NEW CLINICAL APPLICABILITY, OF A CLINICAL‐GENETIC RISK MODEL THAT PREDICTS THROMBOSIS WITH HIGH SENSITIVITY IN PATIENTS WITH LYMPHOMA</title><title>Hematological oncology</title><subject>Lymphoma</subject><subject>Thromboembolism</subject><subject>Thrombosis</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OwkAUhSdGExHd-QCTuKU4P22ZLksZ6MT-hY4QVhMobYQgxVZi2PkIrn08n8QhRZau7r053z0nOQDcY9TFCJHHl3LbJdhRxKb4ArQwchwDI9u5BC1EesxAhJJrcFPXa4S0hlgLfLtw4gZi4EoRRx04FdKHEZ9CLxCR8NwAukkS6KUvAiFnHRgPoXsWfz6_RjziUnhwLNInGMYDHkDpuxImYz4Qnkz1NY7DfpyKtDH3xciHKY9SIcVEW0IRwUSn80ieiGAWJn4curfgqphv6vzuNNvgecil5xtBPDqmGxm2TGxgYtlOscSLZcYoKbDJrBxThB0bZ5ll2gvKehZhy8LOKbG0xrIeKixEaZ6ZCzOjbfDQ-O6q8m2f1-9qXe6rrY5UhJikhxhjRFOdhsqqsq6rvFC7avU6rw4KI3VsX-n21V_7Grca_GO1yQ__ssqPo_PfLw58e-8</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Bastos‐Oreiro, M.</creator><creator>Ortiz, J.</creator><creator>Pradillo, V.</creator><creator>Martinez‐Laperche, C.</creator><creator>Salas, E.</creator><creator>Buño Borde, I.</creator><creator>Díez‐Martín, J.</creator><creator>Soria, J.</creator><creator>Pascual, C.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201906</creationdate><title>A VALIDATION, WITH NEW CLINICAL APPLICABILITY, OF A CLINICAL‐GENETIC RISK MODEL THAT PREDICTS THROMBOSIS WITH HIGH SENSITIVITY IN PATIENTS WITH LYMPHOMA</title><author>Bastos‐Oreiro, M. ; Ortiz, J. ; Pradillo, V. ; Martinez‐Laperche, C. ; Salas, E. ; Buño Borde, I. ; Díez‐Martín, J. ; Soria, J. ; Pascual, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1541-12569fd1bdc832f1485e1301961cc546b387528df6e3255e18c70f5033ec4b4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Lymphoma</topic><topic>Thromboembolism</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bastos‐Oreiro, M.</creatorcontrib><creatorcontrib>Ortiz, J.</creatorcontrib><creatorcontrib>Pradillo, V.</creatorcontrib><creatorcontrib>Martinez‐Laperche, C.</creatorcontrib><creatorcontrib>Salas, E.</creatorcontrib><creatorcontrib>Buño Borde, I.</creatorcontrib><creatorcontrib>Díez‐Martín, J.</creatorcontrib><creatorcontrib>Soria, J.</creatorcontrib><creatorcontrib>Pascual, C.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bastos‐Oreiro, M.</au><au>Ortiz, J.</au><au>Pradillo, V.</au><au>Martinez‐Laperche, C.</au><au>Salas, E.</au><au>Buño Borde, I.</au><au>Díez‐Martín, J.</au><au>Soria, J.</au><au>Pascual, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A VALIDATION, WITH NEW CLINICAL APPLICABILITY, OF A CLINICAL‐GENETIC RISK MODEL THAT PREDICTS THROMBOSIS WITH HIGH SENSITIVITY IN PATIENTS WITH LYMPHOMA</atitle><jtitle>Hematological oncology</jtitle><date>2019-06</date><risdate>2019</risdate><volume>37</volume><issue>S2</issue><spage>534</spage><epage>534</epage><pages>534-534</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.219_2631</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2019-06, Vol.37 (S2), p.534-534 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_2242708882 |
| source | Wiley Online Library All Journals |
| subjects | Lymphoma Thromboembolism Thrombosis |
| title | A VALIDATION, WITH NEW CLINICAL APPLICABILITY, OF A CLINICAL‐GENETIC RISK MODEL THAT PREDICTS THROMBOSIS WITH HIGH SENSITIVITY IN PATIENTS WITH LYMPHOMA |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A25%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20VALIDATION,%20WITH%20NEW%20CLINICAL%20APPLICABILITY,%20OF%20A%20CLINICAL%E2%80%90GENETIC%20RISK%20MODEL%20THAT%20PREDICTS%20THROMBOSIS%20WITH%20HIGH%20SENSITIVITY%20IN%20PATIENTS%20WITH%20LYMPHOMA&rft.jtitle=Hematological%20oncology&rft.au=Bastos%E2%80%90Oreiro,%20M.&rft.date=2019-06&rft.volume=37&rft.issue=S2&rft.spage=534&rft.epage=534&rft.pages=534-534&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.219_2631&rft_dat=%3Cproquest_cross%3E2242708882%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2242708882&rft_id=info:pmid/&rfr_iscdi=true |